Out-of-pocket medical spending for care in patients with recent onset rheumatoid arthritis

被引:0
作者
Westhoff, G [1 ]
Listing, J [1 ]
Zink, A [1 ]
机构
[1] Deutsch Rheuma Forschungszentrum, Forschungsbereich Epidemiol, D-10117 Berlin, Germany
来源
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2004年 / 63卷 / 05期
关键词
out-of-pocket medical spending; rheumatoid arthritis; disease severity; alternative treatment;
D O I
10.1007/s00393-004-0650-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We examined out-of-pocket medical expenditures (OoP) of 869 patients with recent onset rheumatoid arthritis (ACR criteria, disease duration <2 years) using data from a prospective observational cohort. Out-of-pocket costs were retrospectively assessed for a period of 6 months by a list of 14 cost domains. Of the patients, 82% had costs due to co-payments for prescribed drugs and 56% for over-the-counter drugs. Within six months each patient spent an average of 47 (+/-67) Euro as co-payment and (+/- 96) Euro for over-the-counter drugs. A comparable sum was spent for complementary and alternative medicine (47 +/- 250 Euro), which was used by 14% of the patients. The mean total OoP expenditure caused by RA was 628 Euro p.a. (median 306, IQ 66-334 Euro). The median costs accounted for approximately 2% of the average disposable yearly income in Germany. Out-of-pocket spending increased with functional limitations, poor health condition and pain as well as with level of education. A multivariate logistical regression analysis showed that patients with these characteristics spent about twice as much as patients with mild disease or low educational level. The odds ratios for having more than 306 Euro OoP-costs p.a. were OR = 2.6 (Cl 1.7-4) for patients with severe vs. moderate functional disability (HAQ greater than or equal to 1.5 vs < 1.5), OR = 2.4 (CI 1.4-4.4) for patients in poor vs. good health condition (NRS 7-10 vs 0-3), and OR = 2.1 for patients with severe vs. mild pain (CI 1.4-3.3). The level of OoP spending also varied by employment status (OR = 0.28; Cl 0.1-0.6 for jobless vs employed patients). Despite almost universal insurance coverage in Germany, patients with rheumatoid arthritis were exposed to substantial OoP expenditures. As policyrnakers discuss cost sharing and design of benefit packages to contain health spending, it is important to consider the expenditures that persons with chronic conditions like rheumatoid arthritis already have.
引用
收藏
页码:414 / 424
页数:11
相关论文
共 27 条
[1]  
ACHMAN L, 2002, PR0210 COMM FUND
[2]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[3]   Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis - Results from the Norfolk Arthritis Register study, a large inception cohort [J].
Bukhari, M ;
Lunt, M ;
Harrison, BJ ;
Scott, DGI ;
Symmons, DPM ;
Silman, AJ .
ARTHRITIS AND RHEUMATISM, 2002, 46 (04) :906-912
[4]  
Crystal S, 2000, J GERONTOL B-PSYCHOL, V55, pS51
[5]   Cost of illness studies in rheumatic diseases [J].
Fautrel, B ;
Guillemin, F .
CURRENT OPINION IN RHEUMATOLOGY, 2002, 14 (02) :121-126
[6]  
Gabriel SE, 1997, J RHEUMATOL, V24, P719
[7]   Survival in rheumatoid arthritis - A population-based analysis of trends over 40 years [J].
Gabriel, SE ;
Crowson, CS ;
Kremers, HM ;
Doran, MF ;
Turesson, C ;
O'Fallon, WM ;
Matteson, EL .
ARTHRITIS AND RHEUMATISM, 2003, 48 (01) :54-58
[8]  
GROSS D, 1999, OUT POCKET SPENDING
[9]   Why do patients with rheumatoid arthritis use alternative treatments? [J].
Jacobs, JWG ;
Kraaimaat, FW ;
Bijlsma, JWJ .
CLINICAL RHEUMATOLOGY, 2001, 20 (03) :192-196
[10]  
Kaboli PJ, 2001, ARTHRIT RHEUM-ARTHR, V45, P398, DOI 10.1002/1529-0131(200108)45:4<398::AID-ART354>3.0.CO